ARTV earnings date and last-quarter result: last quarter miss, P/E -2.82. Updated 2026-07-23.
Artiva Biotherapeutics (ARTV) Research Hub
Artiva Biotherapeutics (ARTV) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 6.16 USD (+0.16%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.82, market cap 0.24B. This hub links to the full technical, earnings and options research available for ARTV.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 6.16 USD (+0.16%) |
| 52-week range | 5.76 USD – 12.27 USD |
| Trend regime | Range |
| 14-day RSI | 32.3 (Bearish) |
| Trailing P/E | -2.82 |
| Market cap | 0.24B |
| Dividend yield | 0.00% |
Available research for ARTV
Covered Call on ARTV: how it works, illustrative setup around the real 6.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ARTV: how it works, illustrative setup around the real 6.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ARTV: how it works, illustrative setup around the real 6.16 USD price, max profit/loss, breakeven and when to use it. Educational.
ARTV technical analysis: range, last 6.16 USD, RSI 32.3, 52w range 5.76 USD–12.27 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ARTV in?
Artiva Biotherapeutics (ARTV) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ARTV in an uptrend or downtrend?
As of 2026-10-26, ARTV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ARTV's trailing P/E ratio?
ARTV's trailing P/E is -2.82, with a market cap of 0.24B. See the earnings research page for full valuation detail.